THERESA LAWSON: Open Payments
NPI 1326071226 · GREENWOOD, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 34 payments from 10 companies in 2025. Trend: 2023 $230 · 2024 $759 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Novo Nordisk Inc | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $52 |
| Tris Pharma Inc | 3 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $31 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $26 |
| Corcept Therapeutics | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, Wegovy, TRINTELLIX, Dyanavel XR, Jornay PM, QULIPTA, OTEZLA.
Industry payments across SC — which companies pay providers there.
